LEES PHARMACEUTICAL HLDGS financial statements, including revenue, expenses, profit, and loss

The total revenue of 950 for the last semiannual is 658.35 M HKD, and it's 21.75% higher compared to the previous semiannual. The net income of H1 24 is 62.48 M HKD.